Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 196 of 1,261

  1. US 11642374

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2023 · Expires May 4, 2043

    granted

  2. US 11642319

    Targeted nanogels for urinary bladder therapies

    The Regents of the University of Colorado · Granted May 9, 2023 · Expires May 4, 2043

    granted

  3. US 11643656

    Antisense therapies for treating cancer

    The United States Government represented by the Department of Veterans Affairs · Granted May 9, 2023 · Expires May 4, 2043

    granted

  4. US 11642849

    In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted

  5. US 11643394

    Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease

    United States Government as represented by the Department of Veterans Affairs · Granted May 9, 2023 · Expires May 4, 2043

    granted

  6. US 11643438

    Antimicrobial peptides and methods of use

    The Board of Regents of the University of Oklahoma · Granted May 9, 2023 · Expires May 4, 2043

    granted

  7. US 11642419

    Compositions and methods for treating cardiovascular related disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 9, 2023 · Expires May 4, 2043

    granted

  8. US 11642410

    Targeting microbubbles

    The Regents of the University of California · Granted May 9, 2023 · Expires May 4, 2043

    granted

  9. US 11642398

    Factor IX polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  10. US 11643453

    Cell

    AUTOLUS LIMITED · Granted May 9, 2023 · Expires May 4, 2043

    granted

  11. US 11643640

    Rift valley fever vaccine

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted

  12. US 11642379

    Hematopoietic stem cell engraftment

    The Regents of the University of California · Granted May 9, 2023 · Expires May 4, 2043

    granted

  13. US 11642366

    Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

    GLYCOMIRA THERAPEUTICS, INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  14. US 11642364

    Exon skipping oligomer conjugates for muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  15. US 11642332

    (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted May 9, 2023 · Expires May 4, 2043

    granted

  16. US 11643446

    Progranulin variants

    DENALI THERAPEUTICS INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  17. US 11642339

    Methods of treating symptoms of gastroparesis using velusetrag

    Theravance Biopharma R&D IP, LLC · Granted May 9, 2023 · Expires May 4, 2043

    granted

  18. US 11642323

    Method for modulating metabolism

    Brightseed, Inc. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  19. US 11642354

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted

  20. US 11642384

    Compositions and methods for the treatment of Netherton Syndrome

    Krystal Biotech, Inc. · Granted May 9, 2023 · Expires May 4, 2043

    granted

  21. US 11642335

    Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs

    The Board of Regents of the University of Texas System · Granted May 9, 2023 · Expires May 4, 2043

    granted

  22. WO 2023077094

    TRAITEMENT D'UN TROUBLE DÉPRESSIF MAJEUR

    ABBVIE INC [US] · Granted May 4, 2023 · Expires Apr 29, 2043

    granted

  23. CA 3234495

    POLYTHERAPIE DE COMPLEXE DE RADIONUCLEIDES

    NOVARTIS AG [CH] · Granted May 4, 2023 · Expires Apr 29, 2043

    granted

  24. WO 2023076144

    MÉTHODES ET COMPOSITIONS DESTINÉES À AMÉLIORER LA PRODUCTION ET LA SÉCRÉTION D'INSULINE

    ABBOTT LAB [US] · Granted May 4, 2023 · Expires Apr 29, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.